Newron Pharmaceuticals SpA - Company Profile
Powered by 
All the data and insights you need on Newron Pharmaceuticals SpA in one report.
$295
- Save hours of research time and resources with
our up-to-date Newron Pharmaceuticals SpA Strategy Report
- Understand Newron Pharmaceuticals SpA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Newron Pharmaceuticals SpA Clinical Trials
Determine Newron Pharmaceuticals SpA go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Newron Pharmaceuticals SpA Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A Phase IIb/III, Randomized, 4-week, Placebo-controlled Study, Designed to Determine the Safety, Tolerability, and Efficacy of Evenamide (NW-3509) in Patients with Chronic Schizophrenia. | GDCT0417350 | evenamide | Central Nervous System | Schizophrenia | Phase II/III | Ongoing, recruiting | Newron Pharmaceuticals SpA |
| A Four-week, Single dose, Cross-over Thorough QT (TQT) Study to Evaluate the Effects of Evenamide (30 mg and 60 mg) Compared with Placebo and Moxifloxacin 400 mg on the QT Segment in Healthy Subjects | GDCT0417349 | evenamide | Central Nervous System | Schizophrenia | Phase I | Completed | Newron Pharmaceuticals SpA |
| Long Term Fixed Doses of Evenamide in Patients with Treatment-resistant Schizophrenia | GDCT0398726 | evenamide | Central Nervous System | Schizophrenia | Phase II | Ongoing, recruiting | Newron Pharmaceuticals SpA |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer